Clinical trials
PARKINSON DISEASE (Disorder) clinical trials
Below are recruiting parkinson disease (disorder) clinical trials, each written for real people, not researchers. We’re tracking 496 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07281794Recruiting
Testing a wearable system for walking and balance in Parkinson's
This study tests a wearable system (DANU Sports) that measures how you walk and keep your balance. It aims to see if the system can help people with Parkinson's disease track their movement problems.
Newcastle upon Tyne, Tyne and WearAges 50 years+ - NCT06582355Recruiting
Brain training with MRI for Parkinson's disease
This study tests whether a brain-training technique called neurofeedback can help people with Parkinson's disease. You will learn to control certain brain signals while having an MRI scan, which may improve your symptoms.
CologneAges 18 years+ - NCT07277205Recruiting
Balance and thinking exercises for Parkinson's disease
This study compares two types of rehabilitation exercises for people with Parkinson's disease: one focusing on balance (vestibular) and one combining balance with thinking tasks (dual-task). It aims to see which is better at improving balance and daily function. If you are between 40 and 75, have mild to moderate Parkinson's, and can do cognitive tasks, you might be eligible.
Istanbul, MaltepeAges 40–75 - NCT07250672Recruiting
3D video training for Parkinson's movement
This trial tests if watching personalized 3D videos of movements can help improve walking and other skills in people with Parkinson's. It involves using a special viewer to watch actions that match your own needs.
Bolu, BoluAges 50–85 - NCT06388863Recruiting
Fecal transplant for constipation in Parkinson's disease
This study tests whether a treatment called fecal microbiota transplantation (FMT) can help relieve constipation in people with Parkinson's disease. FMT uses healthy donor stool to improve gut bacteria, which may ease constipation and possibly improve Parkinson's symptoms.
Shanghai, Shanghai MunicipalityAges 40–75 - NCT06906679Recruiting
Upper limb rehab for Parkinson's disease
This trial tests an upper limb rehabilitation program for people with Parkinson's disease. It aims to improve arm and hand function while on regular medication.
Cassino, FRAges 30–80 - NCT07227896Recruiting
Study of a new pump treatment for advanced Parkinson's
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
Georgetown, TexasAges 18–80 - NCT06916260Recruiting
Light therapy study for people with Parkinson's disease
This study tests whether light therapy can help people with Parkinson's disease. Participants will receive light therapy sessions and have their symptoms checked before, after, and three months later.
Newark, DelawareAges 50–80 - NCT07213856Recruiting
Dietary help for constipation in Parkinson's disease
This study tests whether a special diet can help improve constipation symptoms in people with early-stage Parkinson's disease. It aims to see if changing what you eat can make bowel movements more regular and comfortable.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT06573762Recruiting
Home monitoring for Parkinson's disease
This study uses a Fitbit to track movement and symptoms from home. It is for people who are newly referred or recently diagnosed with Parkinson's disease.
Iowa City, IowaAges 50–110 - NCT07175922Recruiting
A study of gene changes in people with Parkinson's disease
This study looks at how the csgA gene changes over time in people with Parkinson's disease, especially if they have stomach or bowel issues. It aims to help understand how these changes might relate to symptoms.
LeidenAges 18–80 - NCT07157345RecruitingPhase 1
Testing PDR-001 for Parkinson's Disease
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
Shanghai, Shanghai MunicipalityAges 40–65 - NCT07157735RecruitingPhase 2
Testing an anti-inflammatory drug for early Parkinson's disease
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
CambridgeAges 50–80 - NCT06732180RecruitingPhase 1
Testing a new drug (GT-02287) for Parkinson's disease
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
Darlinghurst, New South WalesAges 30–85 - NCT07118956Recruiting
Ear stimulation for apathy in Parkinson's
This trial tests whether a gentle electrical stimulation on your ear (taVNS) can help improve low motivation (apathy) in people with Parkinson's. It also uses MRI scans to see how the treatment affects the brain.
Hefei, AnhuiAges 40–90 - NCT07110376Recruiting
Brain recordings during sleep with deep brain stimulation for Parkinson's
This study looks at brain activity during sleep in people with Parkinson's who have a deep brain stimulation (DBS) device. It aims to understand how different DBS settings affect sleep, which may help improve treatment.
Cleveland, OhioAges 18 years+ - NCT07102342RecruitingPhase 1/Phase 2
Cell therapy for Parkinson's disease
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
New York, New YorkAges 30–75 - NCT06977204Recruiting
Exercise and brain health in Parkinson's disease
This study looks at whether physical activity can reduce inflammation in the brain for people with Parkinson's disease. It aims to understand how exercise might help slow the progression of the disease.
Pavia, PaviaAges 40–80 - NCT07057219Recruiting
Steps Against Parkinson's: walking exercise program
This trial tests a program to help people with Parkinson's disease improve their walking and balance through physical exercise. It's for people in early to moderate stages who have some walking trouble.
Randwick, New South WalesAges 18 years+ - NCT07020026RecruitingPhase 2
Tau brain scan study for Parkinson's and related disorders
This study uses a special PET scan to measure tau protein buildup in the brain of people with Parkinson's disease (including those with a LRRK2 gene mutation), Progressive Supranuclear Palsy, or Corticobasal Syndrome. It aims to better understand how tau relates to these conditions.
New Haven, ConnecticutAges 45–85 - NCT07022522Recruiting
Brain stimulation frequencies for impulse control in Parkinson's
This study tests whether stimulating specific parts of the brain's subthalamic nucleus at different frequencies can improve control over unwanted movements or impulses in people with Parkinson's disease. If you are planning to have DBS surgery, this trial may help find a better way to use the device.
Beijing, Beijing MunicipalityAges 40–80 - NCT07005180RecruitingPhase 2
Carbon monoxide gas for Parkinson's disease
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
Fountain Valley, CaliforniaAges 40–80 - NCT07010328Recruiting
AI-guided posture training for Parkinson's disease
This trial tests whether a special training program that uses artificial intelligence can help improve posture in people with Parkinson's disease who have a forward bend or lean to one side. If you have Parkinson's and a noticeable postural problem, this might be a way to try a new approach to rehabilitation.
Pavullo nel Frignano, PaviaAges 18 years+ - NCT06999330Enrolling by invitation
TMS for anxiety in Parkinson's disease
This study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain treatment, can help reduce anxiety in people with Parkinson's disease. You may qualify if you have both Parkinson's and significant anxiety symptoms.
Saint Paul, MinnesotaAges 40–90
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson disease (disorder)?
- Yes. Clin2 currently lists 496 recruiting parkinson disease (disorder) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson disease (disorder) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson disease (disorder) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.